Fwd: Heavy Drinking May Create Inflammation That May Be Linked To Heart Disease, Other Health Problems, Study Suggests

[Okechukwu Ogah]

---------- Forwarded message ----------
From: ACC CV News Digest <ACCE...@acc.bulletinhealthcare.com>
Date: Friday, December 27, 2019
Subject: Heavy Drinking May Create Inflammation That May Be Linked To Heart Disease, Other Health Problems, Study Suggests
To: osoga...@gmail.com

An exclusive benefit of your ACC membership

If you are unable to see the message or images below, click here to view

December 27, 2019

Research News Heavy Drinking May Create Inflammation Linked To Heart Disease, Other Health Problems, Study Suggests HealthDay (12/24, Preidt) reports on a recent study that “analyzed three blood indicators of heart damage in more than 2,500 adults, ages 35-69, in northwest Russia,” with “nearly 250 [of those analyzed]...being treated at a hospital for alcoholism.” When “compared to non-problem drinkers in the general population, the hospital patients had more than 10% higher indicators for heart injury; about a 47% higher indication for cardiac wall stretch; and about a 69% higher odds for inflammation.” The findings were published in the Journal of the American Heart Association. Research Indicates Traffic-Related Pollution Increases Risk For High Blood Pressure In Pregnant Women HealthDay (12/26, Preidt) reports federal research from the National Institute of Environmental Health Sciences’ National Toxicology Program indicates “air pollution from vehicles increases the risk of dangerously high blood pressure in pregnant women.” The study “also found that women who live within a quarter mile of a major roadway or in areas with high levels of traffic may be at an increased risk for preeclampsia.”

From ACC Call For Applications: Course Director of ACC CV Overview and Board Review Course. The ACC is seeking a qualified candidate to serve as course director for the ACC Cardiovascular Board Review and Overview Course – taking place Sept. 7-12, 2020, in Washington, DC. The commitment will be for a one-year term and the new course director will work in collaboration with the current course director, Patrick T. O’Gara, MD, MACC, and ACC staff to develop the educational course, and in selecting and preparing the faculty team. Interested candidates are encouraged to review the position description and complete the application form. A cover letter highlighting credentials as well as a curriculum vitae should be submitted along with the application to Camille Haynes at cha...@acc.org, on or before midnight on Friday, Jan. 17. Learn more about the position. Connect with the ACC online:

Clinical News Early Vasodilator Therapy Does Little To Improve Survival, Other Clinical Outcomes For Patients Hospitalized With Acute HF, Trial Indicates Medscape (12/26, Stiles, Subscription Publication) reports “early vasodilator therapy, even when aggressive, does little to improve survival or other clinical outcomes for patients hospitalized with acute heart failure (HF), suggests only the latest randomized trial to downplay the role of vasodilators in that setting.” The results of “the GALACTIC trial showed no difference in death or acute-HF rehospitalization at 6 months among patients who received usual care compared to those who received an intensive strategy based on early initiation of multiple vasodilators.” The trial was reported in the Journal of the American Medical Association. Industry News FDA Does Not Approve Vernakalant For Irregular Heart Rhythm Reuters (12/24, Joseph, Singh) reported the FDA “declined to approve Correvio Pharma Corp’s drug [Brinavess] to correct irregular rhythm in the upper chambers of the heart.” In a complete response letter, the agency “stated that while the submitted data provides substantial evidence of the drug’s effectiveness, the data does not provide reassuring evidence of Brinavess’ [vernakalant] safety.” The article says that earlier this month, an FDA advisory panel “voted 11-2 against” the drug, “citing serious safety risks, including low blood pressure and irregular rhythm in the lower heart chambers during the trials.” Also in the News Review Study Suggests Intermittent Fasting May Be Lower Cholesterol, Blood Pressure, Among Other Benefits USA Today (12/25, Lam) reported researchers conducted a review study on intermittent fasting and concluded that the practice “could yield health benefits from lower cholesterol to reduced stress.” The study was published in the New England Journal of Medicine.         CNN (12/25, Andrew) reported on its website that the study “suggests that intermittent fasting can reduce blood pressure, aid in weight loss and improve longevity.” The study offers “a road map of sorts for physicians to prescribe fasting as a method of prevention or treatment for obesity, cancer, diabetes and heart disease.”         Newsweek (12/25, Gander) reported the study’s “authors said more research needs to be done to see if fasting is safe and beneficial in populations that haven’t yet been studied, as most focus on overweight younger and middle-aged adults.”         HealthDay (12/26, Thompson) also covers the story. Tuesday's Lead Stories  • Use Of PCI, CABG For Treatment Of Left Main CAD Or Low Or Intermediate Anatomic Complexity May Be Associated With Comparable Rates Of Death, Stroke, MI At Five Years, Researchers Say  • Regular Exercise May Reduce Heart Risk Factors In Children With Overweight And Obesity, Researchers Say  • FDA Approves First Generic Version Of Apixaban  • AKI Following PCI May Add Extra $10,000 In Costs, Study Estimates

Subscriber Tools • Send Feedback • Unsubscribe • Email Help • Archives Advertise with BulletinHealthcare: Reach key professionals every morning

CV News Digest is a daily news briefing selected from thousands of sources by the editors of BulletinHealthcare. The mission of CV News Digest is to alert members of the American College of Cardiology about cardiovascular-related information that their patients may read or hear in the media that day. Opinions expressed in CV News Digest are those of the identified authors and do not necessarily reflect the opinions or policies of the ACC. On occasion, media articles may include or imply incorrect information about the ACC and its policies, positions, or relationships. For clarification on ACC positions and policies, we refer you to ACC.org. The presence of advertising does not endorse, or imply endorsement of, any products or services by the ACC. This complimentary copy of the CV News Digest was sent to osoga...@gmail.com as part of your ACC membership. To see how we protect our data, or for any questions on data access, view BulletinHealthcare's privacy policy. To prevent mailbox filters from deleting your CV News Digest, add ACCEditor@acc.bulletinhealthcare.com to your address book. For information about other member benefits, please contact ACC Member Relations at 1-800-253-4636. American College of Cardiology | Heart House | 2400 N Street, NW | Washington, DC 20037 Copyright © 2019 by BulletinHealthcare | 11190 Sunrise Valley Drive, Suite 20 | Reston, VA 20191

--

Dr O.S Ogah. MBBS, MSc, PhD, FWACP, FACP, FESC.
Consultant Cardiologist,
Division of Cardiology
Department of Medicine,
University College Hospital Ibadan
PMB 5116, Ibadan, Oyo State, NIGERIA
Tel. +234 806 77 47 121
Fax. +1215-975-6817 (Electronic)
Email: osoga...@yahoo.com  OR osoga...@gmail.com

https://www.researchgate.net/profile/Okechukwu_Ogah4/contributions

AND

Bernard Lown Visiting Scholar in Cardiovascular Health

Department of Global Health and Population

Harvard T.H. Chan School of Public Health

Email: oo...@hsph.harvard.edu

--------------------------------------------------------------------------------------------------------------------------------------------------

"For with thee is the fountain of life: in thy light shall we see light." Psalm 36:9

-------------------------------------------------------------------------------------------------